Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-05

FDA Approved: RANOLAZINE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's generic ranolazine for chronic angina as an original ANDA approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)